Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.
Adult
Anti-Bacterial Agents
/ therapeutic use
Anti-Infective Agents
/ therapeutic use
Azithromycin
/ therapeutic use
Bacterial Infections
/ epidemiology
COVID-19
/ epidemiology
Ceftriaxone
/ therapeutic use
Coinfection
/ drug therapy
Drug Prescriptions
Female
Humans
Male
Meropenem
/ therapeutic use
Pakistan
/ epidemiology
Prevalence
COVID-19 Drug Treatment
Covid-19
Hospitalized
Pakistan
Punjab
antimicrobial
surveillance
use
Journal
Pathogens and global health
ISSN: 2047-7732
Titre abrégé: Pathog Glob Health
Pays: England
ID NLM: 101583421
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
pubmed:
17
11
2021
medline:
24
9
2022
entrez:
16
11
2021
Statut:
ppublish
Résumé
There are reports of high rates of antibiotic prescribing among hospitalized patients with COVID-19 around the world. To date, however, there are few reports of prescribing in relation to COVID-19 in Pakistan. Herein, we describe a point prevalence survey of antibiotic prescribing amongst patients hospitalized with suspected or proven COVID-19 in Pakistan. A Point Prevalence Survey (PPS) was undertaken in seven tertiary care health facilities in Punjab Provence, Pakistan. Baseline information about antimicrobial use according to the World Health Organization (WHO) standardized methodology was collected on a single day between 5
Identifiants
pubmed: 34783630
doi: 10.1080/20477724.2021.1999716
pmc: PMC9518253
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Infective Agents
0
Ceftriaxone
75J73V1629
Azithromycin
83905-01-5
Meropenem
FV9J3JU8B1
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
421-427Références
Infect Prev Pract. 2021 Jun;3(2):100134
pubmed: 34316576
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
PLoS One. 2017 Dec 21;12(12):e0189621
pubmed: 29267306
Expert Rev Anti Infect Ther. 2022 Jan;20(1):71-93
pubmed: 34038294
Infect Dis (Lond). 2020 Jul;52(7):473-478
pubmed: 32314624
BMC Infect Dis. 2021 Mar 6;21(1):244
pubmed: 33676421
Trans R Soc Trop Med Hyg. 2021 Oct 1;115(10):1122-1129
pubmed: 33772597
Antimicrob Resist Infect Control. 2021 Feb 3;10(1):28
pubmed: 33536077
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629
pubmed: 32711058
Int J Infect Dis. 2021 Apr;105:256-260
pubmed: 33508478
Infect Drug Resist. 2021 May 24;14:1893-1903
pubmed: 34079300
Infect Drug Resist. 2019 Dec 20;12:3903-3910
pubmed: 31908502
Antibiotics (Basel). 2021 Jun 18;10(6):
pubmed: 34207020
Life (Basel). 2021 Jun 07;11(6):
pubmed: 34200116
Biomed Res Int. 2017;2017:4304973
pubmed: 29457026
Bull World Health Organ. 2020 Jul 1;98(7):442-442A
pubmed: 32742026
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Infect. 2020 Dec;81(6):952-960
pubmed: 32987097
Expert Rev Anti Infect Ther. 2022 Jan;20(1):131-136
pubmed: 34047247
JAC Antimicrob Resist. 2020 Sep;2(3):dlaa071
pubmed: 32864608
Lancet Infect Dis. 2019 Dec;19(12):1278-1280
pubmed: 31782385
Ther Adv Infect Dis. 2020 Dec 7;7:2049936120978095
pubmed: 33335724
Lancet Glob Health. 2019 Jul;7(7):e861-e871
pubmed: 31200888
BMC Infect Dis. 2021 Jun 2;21(1):516
pubmed: 34078301
Virusdisease. 2021 Jun;32(2):330-337
pubmed: 34056051
SN Compr Clin Med. 2021;3(8):1691-1695
pubmed: 34095752
J Glob Antimicrob Resist. 2021 Mar;24:45-47
pubmed: 33307276
Lancet Microbe. 2021 Aug;2(8):e354-e365
pubmed: 34100002
Hosp Pract (1995). 2019 Aug;47(3):149-154
pubmed: 31180791
Nat Rev Microbiol. 2019 Jan;17(1):3
pubmed: 30467331
J Antimicrob Chemother. 2020 Nov 1;75(11):3386-3390
pubmed: 32766706
Expert Rev Anti Infect Ther. 2020 Sep;18(9):897-910
pubmed: 32394754
Expert Rev Anti Infect Ther. 2022 Jun;20(6):931-939
pubmed: 34591720
J Infect. 2021 Sep;83(3):e12-e13
pubmed: 34329675
Health Policy Plan. 2020 Oct 1;35(8):973-982
pubmed: 32743655
Infect Drug Resist. 2020 Dec 29;13:4713-4738
pubmed: 33402841
Pathog Glob Health. 2019 Jun;113(4):191-205
pubmed: 31215326
Expert Rev Anti Infect Ther. 2019 Apr;17(4):285-293
pubmed: 30755077
Lancet Infect Dis. 2018 Oct;18(10):1066-1067
pubmed: 30303099
Euro Surveill. 2012 Nov 15;17(46):
pubmed: 23171822